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CASE REPORT
NEEDLE TRACK SEEDING OF PRIMARY AND
SECONDARY LIVER CARCINOMA AFTER
PERCUTANEOUS LIVER BIOPSY
TIMOTHY G. JOHN and O. JAMES GARDEN
University Department of Surgery, The Royal Infirmary, Edinburgh
(Received 17 December 1991)
Seeding of tumour in the needle track following percutaneous needle biopsy of liver neoplasms is rarely
reported. We describe two such cases following the needle biopsy of an hepatocellular carcinoma and
secondary colorectal carcinoma respectively. The risk of needle track recurrence of liver tumours should
not be regarded as insignificant. The diagnosis of liver neoplasms may be achieved by non-invasive
modalities, and their needle biopsy should be reserved for cases not amenable to surgical resection.
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INTRODUCTION
Percutaneous needle biopsy is a commonly used technique in the diagnosis of
malignant abdominal tumours, and it is widely held that the advantage of a high
diagnostic yield outweighs the low complication rate. In particular, the recurrence
of tumour in the biopsy track is said to be rare, with seeding frequencies of 0.005-
0.009% quoted for large series of fine-needle abdominal biopsies1’2. However, as
isolated cases of needle track seeding continue to be reported, there have been calls
for caution in view of this real, albeit small, risk. We report two cases where local
dissemination of primary and secondary liver carcinomas occurred following
percutaneous needle biopsy.
CASE REPORTS
Case 1
A 71 year old male presented with epigastric pain, anorexia and weight loss, and
examination revealed irregular hepatomegaly. A 10 cm mass occupying the left
lobe of the liver was seen on ultrasound scan. Serum ,-glutamyl transferase and
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alkaline phosphatase were elevated at 313/z/l (normal range 0-45/z/l) and 373
(normal range 60-260/z/l) respectively. Serum a-fetoprotein was markedly raised
at 14 700/z/l (normal range 0-15
A Trucut(R) (Travenol Laboratories Inc., Illinois, USA) liver biopsy was
attempted and a single core of normal subcapsular liver tissue obtained. An
ultrasound guided needle biopsy using two passes through the left upper quadrant
of the abdomen with an 18G Surecut(R) needle yielded tissue reported as poorly
differentiated hepatocellular carcinoma. The patient was referred for consideration
of hepatic resection.
An iodised oil emulsion (IOE) enhanced CT scan and hepatic angiography
demonstrated a vascular, lobulated tumour, arising in segments 2 and 3, and
extending into segment 4. No extrahepatic tumour extension was demonstrated on
CT scanning of the abdomen and thorax, and the tumour was considered suitable
for left hemihepatectomy. At laparotomy, two months after initial presentation, a 2
x 0.5 cm hard nodule was discovered in the left rectus muscle with several further
nodules in the underlying falciform ligament. This coincided with the site of the
repeat needle biopsy and histology confirmed metastatic hepatocellular carcinoma.
Operative ultrasonography demonstrated tumour confined to the left hemiliver
with the middle hepatic vein free of tumour. There was no evidence of further
peritoneal dissemination, but no resection was undertaken in view of the local
tumour spread. Hepatic arterial embolization with Lipiodol and Adriamycin was
performed one month later but not tolerated well, and further intervention was
deemed inappropriate. The patient died three months later from locally invasive
tumour.
Case 2
A 59 year old female presented in September 1989 with malaise, anorexia and
weight loss, and was found to have four fingerbreadth hepatomegaly. She had a
past history in 1983 of resection of a tubulovillous adenoma of the sigmoid colon.
Histology had indicated marked glandular dedifferentiation with an area of early
invasion of the muscularis mucosa. Serial barium enemas and colonoscopies were
normal until January 1989 when a further tubulovillous adenoma of the rectum was
excised. An ultrasound and CT scan demonstrated a solitary mass confined to the
right hemiliver. A Trucut biopsy of the liver lesion under ultrasound guidance was
obtained at this stage, the histological appearances of which suggested a secondary
adenocarcinoma and the patient was referred for assessment for hepatic resection.
Hepatitis B serology was negative and serum a-fetoprotein levels normal at 2/z/l
(normal range 2-6/Z/I). Serum carcino embryonic antigen (CEA) levels were
profoundly elevated at 40 800/z/l (normal range 0-35/z/l). An IOE enhanced CT
scan demonstrated a well defined tumour mass involving segments 1,4,5 and 8. The
tumour was judged to be at the limits of resectability, and a course of chemoembo-
lisation was undertaken to provide both symptomatic relief and reduction in
tumour volume sufficient to enable hepatic resection. Three hepatic arterial
embolizations with Adriamycin, Lipiodol and Gelfoam were well tolerated, with
good palliation of symptoms. However, serial CT scans demonstrated no significant
change in tumour size, with serum CEA levels rising to 167 000/Z/I over three
months. She was readmitted in September 1990 with intractable pain whichBIOPSY SEEDING OF LIVER CARCINOMA 201
appeared to be arising from a tender nodule situated over the right eighth rib
laterally at the site of the percutaneous liver biopsy performed 12 months before.
Two discrete hard I cm subcutaneous nodules were biopsied and histology revealed
a well differentiated adenocarcinoma, strongly suggestive of a colonic metastasis.
The patient died two months later from local progression of her tumour.
DISCUSSION
Review of the literature has revealed seven previous cases of local recurrence of
hepatocellular carcinoma in a percutaneous needle biopsy trackl’a-7, and two
instances of needle track seeding of secondary liver tumours8’9; these are summar-
ised in the table. Three cases followed "curative" resection of hepatocellular
carcinomas at 8 month 4 year intervals3’5. Our first case is noteworthy in that the
needle track dissemination of hepatocellular carcinoma was evident at laparotomy
within two months of biopsy, and as with another reported case7, the excision of an
otherwise resectable tumour was precluded. In both cases the biopsies were
unnecessary for diagnosis, as the nature of the malignancy was strongly suggested
by radiological imaging and gross elevation in turnout markers. Both previously
reported cases of recurrence of secondary colonic carcinoma in percutaneous
needle tracks were in patients who had previously undergone hepatic resection, but
who had developed recurrent liver tumour which had been biopsied. In another
case9, extrahepatic turnout recurrence of a secondary rectal carcinoma occurred 13
months following intraoperative direct needle biopsy and wide resection of a deep-
seated solitary liver metastasis, and was attributed to spillage of malignant cells at
the time of biopsy.
It is generally accepted that percutaneous needle biopsy combined with radiolo-
gical imaging is a safe and accurate means of confirming a tissue diagnosis in focal
neoplastic liver disease1,11. The apparent rarity of malignant implantation from
abdominal neoplasms has been emphasised in large series of fine-needle aspiration
biopsies1’2’12, by definition using a needle of 1 mm diameter (19 gauge) or less,
although seeding of pancreatic
13-16 and renal cell carcinoma17 has been described
following this technique. Conventional core-cutting needle biopsy is assumed to
carry an increased risk of seeding, and this has been documented for carcinoma of
the prostateTM, lung
19 and thyroid2. There is no direct evidence that core-cutting
needles significantly increase the risk of tumour seeding, however, and it has been
5 demonstrated in animal models that it is possible to implant 10 -10 tumour cells in
21 the tracks of fine-needle aspiration biopsies Review of the cases where needle
track seeding of liver tumours has occurred reveals no specific association with
core-cutting needles (see Table 1).
The risk of seeding following needle biopsy of liver tumours can no longer be
regarded as insignificant, and this case report provides further evidence that
percutaneous needle biopsy track seeding of liver carcinomas may not be as rare as
has been claimed. Its true incidence is probably under-reported in that many
patients in whom a needle biopsy diagnosis of hepatic malignancy is obtained will
succumb with terminal carcinomatosis before metastasis to the parietes becomes
apparent, although there is no evidence that biopsy of liver tumour adversely
affects survival.
Hepatic resection for hepatocellular carcinoma
22 and colorectal metastases
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Table 1 Liver tumour seeding following percutaneous needle biopsy: reported cases
Patient details Needle type Interval* Ref. No.
N/A 22G (aspiration) 2 months
62 yrs male (HCC) Trucut (core-cutting) 8 months
48 yrs female (HCC) 22G (aspiration) 3 months
70 yrs male (HCC) Trucut (core-cutting) 12 months
64 yrs male (HCC) N/A 4 years
52 yrs female (HCC) 22G (aspiration) 3 years
40 yrs male (HCC) Trucut (core-cutting) 3 weeks
50 yrs female 20-23G (aspiration) 4 months
(colonic metastasis)
74 yrs male ’Thin-needle biopsy’ 17 days
(colonic metastasis)
71 yrs male (HCC) 18G Surecut (core-cutting) 2 months
59 yrs female Trucut (core-cutting) 1 year
(colonic metastasis)
1
3
4
5
5
6
7
8
9
Current
Current
HCC Hepatocellular carcinoma, N/A Details not available
Time interval between liver biopsy and presentation with needle track tumour dissemination.
selected cases now carries low morbidity and mortality rates, and for some offers
the chance of cure. The resectability of hepatic tumours may be assessed by the
non-invasive techniques of ultrasound and contrast-enhanced CT scanning, aug-
mented by hepatic angiography, and early biopsy in the management of focal liver
lesions can usually be avoided24. Percutaneous needle biopsy is only indicated to
obtain an histopathological diagnosis on which to make a treatment decision when
the tumour is irresectable, or to confirm cirrhosis, or other condition precluding
resection, in tumour-free liver.
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INVITED COMMENTARY
This paper clearly demonstrates yet again that no clinical investigation is without
risk. For many years it has been taught by the hepatologists that any space
occupying lesion in the liver should be subjected to percutaneous biopsy to
ascertain its nature. Several of us have urged caution in carrying out this procedure
and this paper reinforces this view since an otherwise curable cancer may be
disseminated by such a technique. It has been argued that fine needle aspiration
will reduce this risk and this is probably true but a risk remains.
I think it is very important to insist that apart from academic studies conducted
within strict protocols, no investigation, especially an invasive one, be carried out
unless it can be demonstrated that the result will affect subsequent management. In
the case of a space occupying lesion in the liver, there are available a multitude of
investigative procedures, as a result of which a fairly certain diagnosis, especially in
relation to its benign or malignant nature, can be made. Once a lesion has been
identified and there is a strong suspicion that it is malignant or if it is causing
symptoms, then the question of surgical resection must be considered. Resection of
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accompanied by a low morbidity and mortality. However this is not so if the
unaffected liver is cirrhotic. If there is clinical evidence to suggest this might be the
case then a needle biopsy of the unaffected liver should be done to confirm or
refute this. If the liver is normal then it is safe to proceed with resection of the
symptomatic or suspicious space occupying lesion without accurate histological
diagnosis in anticipation of total cure. If the liver is cirrhotic then histological
confirmation of the nature of the pathology of the lesion may be fully justified
before considering surgery since the risk of seeding in these circumstances has to be
matched against the risk of unnecessary surgery.
Let us hope that the message clearly expressed in this article will be appreciated,
especially by our medical colleagues who often undertake needle biopsy of
intrahepatic lesions before referring a patient for a surgical opinion.
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Professor of Surgery
INVITED COMMENTARY
This paper clearly documents two further patients in whom an unnecessary
percutaneous needle biopsy of an hepatic tumour has resulted in needle track
seeding. Such biopsies of potentially resectable hepatic lesions are hardly ever
indicated, and may, as in these patients, preclude a later potentially curative
hepatic resection. An increased awareness of this uncommon, but probably under-
reported, complication of percutaneous biopsy should help to reduce the incidence
of this problem.
J.N. Thompson
Senior Lecturer
Hon. Consultant Surgeon
Royal Postgraduate Medical School
Hammersmith Hospital
London W12 0NN